“The Overexpression of ABCG2 Reduces the Efficacy of Volasertib (BI 6727) and GSK641364 in Human S1-M1-80 Colon Carcinoma Cells”. Journal of Cancer Research Updates 3, no. 2 (April 28, 2014):  108–116. Accessed October 21, 2025. https://neoplasiaresearch.com/index.php/jcru/article/view/558.